期刊文献+

17例人微小病毒B19肝炎患者临床特点分析 被引量:3

Clinical characteristics of patients with human parvovirus B19 infection:An analysis of 17 cases
暂未订购
导出
摘要 目的探讨人微小病毒B19肝炎患者的临床特征。方法对17例感染人微小病毒B19患者的病例资料进行回顾性分析,总结肝损害的特点和临床特征。结果 17例人微小病毒B19肝炎患者均有发热(100%),有全身乏力14例(82.4%)、关节、肌肉痛9例(52.9%)、咽痛6例(35.3%)、食欲减退11例(64.7%)、皮疹5例(29.4%)、脾肿大12例(70.6%),肝肿大7例(41.2%)、淋巴结肿大3例(17.6%)、黄疸5例(29.4%);除血ALT和AST升高外,伴有羟丁酸脱氢酶、乳酸脱氢酶、腺苷脱氨酶升高和淋巴细胞百分比升高;起病急,临床表现复杂,但多呈急性自限性过程,肝功能恢复较快,预后较好。结论对不明原因肝损害同时伴有上述特征者,除常规筛查常见的嗜肝病毒外,及时检测血清抗人微小病毒B19抗体Ig M,能帮助明确一部分患者的病因。 Objective To summarize the clinical characteristics of patients with human parvovirus B19 in- fection. Methods The clinical materials in 17 patients with human parvovirus (HPV) B19 infection was retro- spectively summarized,and the clinical features,laboratory findings and radiologic imaging were analyzed. Results The predominant symptoms and signs of patients in this series were:fever (100.0%),general fatigue (82.4%), arthralgia/myalgia (52.9%), pharyngalgia ( 17.4% ), anorexia (64.7%), rash ( 17.3% ), splenomegaly (70.6%), hepatomegaly (41.2%),lymphadenectasis (17.6%) and jaundice (17.3%);The laboratory findings showed elevated serum alanine aminotransferase and aspartate transferase,lactate dehydrogenase,hydroxyhutyrate dehydrogenase and adenosine deaminase levels,and higher lymphocyte counts; Hepatic injury caused by HPV B19 infection had fea- tures of acute onset and complicated clinical manifestations, but with a self-limited illness course. The recovery of liver function was rapid and the prognosis was relatively good. Conclusion The patients who have unex- plained hepatic injury should have a prompt detection of serum anti-HPV B19 IgM,especially in those with nega- tive serum hepatitis A,B, C and E virus markers.
出处 《实用肝脏病杂志》 CAS 2015年第4期364-366,共3页 Journal of Practical Hepatology
关键词 人微小病毒B19 肝损害 临床特征 Human parvovirus B19 Viral hepatitis Clinical features
  • 相关文献

参考文献12

  • 1Pillet S,Fichelson S,Morinet F. Human B19 erythrovirus in vi- tot replication : what' s new?J Virol, 2008,82 ( 17 ) : 8951-8951.
  • 2Wang C,Heim A,Schlaphoff V, et al. Intrahapetic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis. J Med Virol, 2009,81 (12) : 2079-2088.
  • 3Kim BJ,Yoo KH,Li K,et al. Parvovirus B19 infection assosi- ated with acute hepatitis in infant. Padiatr infect Dis J,2009, 28(7) :667-668.
  • 4潘蕾,马春燕,彭梅娟,魏欣,谢玉梅,白雪帆,贾战生.人微小病毒B19感染所致肝损害19例临床分析[J].实用肝脏病杂志,2012,15(4):324-326. 被引量:2
  • 5Yoto Y,Kudoh T,Haseyama K,et al. Human parvovivus B19 in- fection associated with acute hepatitis.Lancet, 1996,347(9005): 868-869.
  • 6Hayakawa H,Tara M,Niina K,et al. Clinical study of adult human parvovims B19 infection.J Intern Med,2002,41 (4): 295-299.
  • 7Nara M,Shirata Y,Kikuchi T,et al. Adult human parvovinls- B19 infection presenting with hearing difficulty and dizziness. Tohoku J Exp Med,2011,224( 1 ) : 57-59.
  • 8郑优荣,李仲平,梁浩坚,黄柏泉,田也.广州地区献血人群人类细小病毒B19感染情况及病毒载量分析[J].中国输血杂志,2009,22(7):549-551. 被引量:11
  • 9张威,柯玲,李长清,张燕,李武平.人细小病毒B19 DNA在中国血浆及血浆制品中的污染研究[J].中国输血杂志,2012,25(S1):87-87. 被引量:2
  • 10Enders M,Klingel K,Weidner A,et al. Risk of fetal hydrops and non-hydropiec late intrauteime fetal death after gestational parvovirus B19 infection. J Clin Virol,2010,49(3): 163-168.

二级参考文献17

  • 1曹虹,贡树基,赵卫,仲华,张文炳.人微小病毒B19感染的研究进展[J].微生物学通报,2007,34(2):332-338. 被引量:19
  • 2Candotti D, Etiz N, Parsyan A, et al. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol,2004,78(22) :12169.
  • 3Serjeant GR,Serjeat BE ,Thomas PW,et al. Human parvovirus infection in homozygous sickle ceil disease. Lancet, 1993, 341 (8855) : 1237-1240.
  • 4Corcoran A, Doyle S. Advances in the biology, diagnosis and hostpathogen interaction of parvovirus B19. J Med Microbiol, 2004,53 (6) : 459-475.
  • 5Beatric J,Tiangco MD,Joseph E,et al. The human parvovirus B19 in transfusion medicine. Transfusion medicine Update, 1996, 8 (1) : 241-244.
  • 6Aubin JT, Defer C, Vidaud M, et al. Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation. Vox Sang,2000,78( 1 ) :7-12.
  • 7Bonvieini F, Gallinella G, Cricca M, et al. Molecular testing for detection of in vitro infectivity of plasma pools contaminated with B19 virus. J Med Virol,2004,74(2):272.
  • 8Tabor E, Yu MY, Hewlett I, et al. Summary of a workshop on the implementation of NAT to screen donors of blood and plasma for viruses[ J]. Transfusion, 2000,40(10) : 1273-1275.
  • 9Pongratz G,Lindner J,Modrow S,et al. Persistent parvovirus B19 infection detected by specific CD4+ T-ceU responses in a patient with hepatitis and polyarthritis. J Intern Med,2009,266 (3):296-301.
  • 10Cao YH,Zhang GY,Zhang GC. Successful treatment with highdose intravenous immunoglobulin for parvovirus b19 infection associated with acute fuhninant hepatitis in a chinese child. Clin Pediatr (Phila),2009,48(6):674-676.

共引文献10

同被引文献13

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部